| Literature DB >> 31386363 |
Masayoshi Miyagawa1, Toshiyuki Akiyama1, Yoshiyuki Taoda1, Kenji Takaya1, Chika Takahashi-Kageyama1, Kenji Tomita1, Kazuya Yasuo1, Kazunari Hattori1, Shinya Shano1, Ryu Yoshida1, Takao Shishido1, Tomokazu Yoshinaga1, Akihiko Sato1, Makoto Kawai1.
Abstract
The medicinal chemistry and structure-activity relationships (SAR) for a novel series of carbamoyl pyridone bicycle (CAB) compounds as influenza Cap-dependent endonuclease (CEN) inhibitors are disclosed. Substituent effects were evaluated at the C (N)-1, N-3, and C-7 positions of the CAB ring system using a docking study. Submicromolar EC50 values were achieved in the cellular assay with C-7-unsubstituted CAB which possessed a benzhydryl group on either the C-1 or the N-1 position. An N-3 substituent was found to be critical for the plasma protein binding effect in vitro, and the CAB-N analogue 2v exhibited reasonable total clearance (CLtot). More importantly, compound 2v displayed significant efficacy in a mouse model infected with influenza viruses.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31386363 DOI: 10.1021/acs.jmedchem.9b00861
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446